John Radford
Brigham Young University(US)Kansas City University(US)York University(CA)Manchester Academic Health Science Centre(GB)University of Manchester(GB)Manchester University NHS Foundation Trust(GB)Cancer Research UK Manchester Institute(GB)The Christie Hospital(GB)The Christie NHS Foundation Trust(GB)NIHR Manchester Biomedical Research Centre(GB)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Lung Cancer Treatments and Mutations, Viral-associated cancers and disorders, CAR-T cell therapy research
Most-Cited Works
- → Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma(2013)1,669 cited
- → Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma(2017)971 cited
- → Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study.(1998)897 cited
- → Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma(2016)779 cited
- → Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma(2017)747 cited
- → Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma(2015)737 cited